Stock Chart
AMLX
Type: SELL wallstreet
Strike: $22
Premium: $6.33
Expiry: Jan 15, 2027
Target: $22
Score: -95
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About AMLX - Amylyx Pharmaceuticals, Inc. Common Stock
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
Key Statistics
More AMLX Analysis
This AMLX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AMLX's price movements with trendlines, gamma walls, and key support/resistance levels.